Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Renovaro Biosciences (RENB) Q1 2023 Earnings
RENB
12
May
Expected
Q4 2021
Q1 2022
Q4 2022
Q1 2023
-1.7
-1.13
-0.57
0
Details
Expected EPS
N/A
Actual EPS
-0.08
Surprise EPS
-0.08
Surprise Percent
+∞%
Description
Renovaro Biosciences (RENB) has reported earnings of -0.08 per share for Q1 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login